Eli Lilly and Company, Q3 FY2026LLLLY+39%Q3 FY2026Eli Lilly and CompanyEli Lilly and Company Q3 FY2026 income flowRevenue $24.4B, gross margin 66.7%, net margin 26.4%.
Johnson & Johnson, Q3 FY2026JNJNJ+5.9%Q3 FY2026Johnson & JohnsonJohnson & Johnson Q3 FY2026 income flowRevenue $25.4B, gross margin 73.0%, net margin 0.8%.Revenue$25.4BGross73.0%Net0.8%
Pfizer Inc., Q2 FY2026PFPFE+2.6%Q2 FY2026Pfizer Inc.Pfizer Inc. Q2 FY2026 income flowRevenue $15.0B, gross margin 72.8%, net loss $248.0M.Revenue$15.0BGross72.8%Net loss$248.0M